Anchyra Partners’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.98M Buy
7,469
+772
+12% +$204K 0.41% 45
2026
Q2
$1.7M Buy
6,697
+339
+5% +$79K 0.41% 47
2026
Q1
$1.55M Buy
6,358
+351
+6% +$81.8K 0.47% 42
2025
Q4
$1.24M Buy
+6,007
New +$1.19M 0.38% 55

Other funds holding JNJ

Anchyra Partners's JNJ Position: Q3 2026 in Review

Anchyra Partners increased its Johnson & Johnson (JNJ) stake by 12% in Q3 2026, buying an estimated $204K and bringing the position to 7,469 shares worth $1.98M. The position accounts for 0.41% of the portfolio, ranked #45.

Anchyra Partners first reported a position in JNJ in Q4 2025 and has held it in 4 quarters since. 4,709 funds tracked by Wall St. Rank hold JNJ as of Q3 2026.

  • Anchyra Partners held 7,469 shares of Johnson & Johnson worth $1.98M as of Q3 2026.
  • Anchyra Partners bought 772 Johnson & Johnson shares in Q3 2026, an estimated $204K.
  • Johnson & Johnson made up 0.41% of Anchyra Partners's portfolio in Q3 2026, its #45 holding.
  • Anchyra Partners first reported a position in Johnson & Johnson in Q4 2025 and has held it in 4 quarters since.
  • 4,709 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2026.

Based on Anchyra Partners's 13F filing for Q3 2026, filed 13 Oct 2026.